Op-Eds

Shut down the FDA’s failed GLP-1 green list

By Michael Burgess

Published June 10, 2026 6:00am ET

Add Washington Examiner on Google

People taking GLP-1 drugs deserve to know exactly what is being injected into their bodies.

A new Food and Drug Administration warning letter shows why they may not.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Bureaucracy China Drugs FDA Medicine Pharmaceutical Industry Weight Loss Drugs